Acute leukemia of unspecified cell type, in relapse is a hematological malignancy characterized by the rapid proliferation of immature blood cells. This condition is clinically significant due to its aggressive nature and potential for rapid deterioration. Accurate coding with ICD-10 Code C95.02 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that patients receive appropriate care and resources.
ICD-10 Code C95.02 represents Acute leukemia of unspecified cell type, in relapse, indicating a recurrence of the disease after a period of remission. This code is used when the specific type of leukemia is not identified, yet the patient exhibits signs of relapse. It is crucial for clinical documentation and billing to ensure accurate representation of the patient's condition and treatment needs.
Acute leukemia of unspecified cell type, in relapse, is caused by genetic mutations leading to uncontrolled proliferation of immature hematopoietic cells. The condition progresses rapidly, often requiring immediate medical intervention to prevent severe complications. Prompt recognition and treatment are critical to improving patient outcomes.
ICD-10 Code C95.02 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans. It plays a vital role in both acute and chronic care settings, ensuring comprehensive documentation that supports clinical decision-making and billing processes.
In SOAP notes, ICD-10 Code C95.02 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of acute leukemia in relapse. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Acute leukemia of unspecified cell type, in relapse, necessitates urgent medical intervention, often requiring hospitalization for intensive treatment.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C95.02 is critical for accurate billing in hospital, ER, or infectious disease care settings.
| CPT Code | Description |
|---|---|
| 85025 | Complete blood count with differential. |
| 36415 | Collection of venous blood by venipuncture. |
| 85027 | Complete blood count with automated differential. |
| 88305 | Pathology examination of tissue. |
Common Questions About Using ICD-10 Code C95.02 for Acute leukemia of unspecified cell type, in relapse
What are the common symptoms of acute leukemia in relapse?
Common symptoms include fatigue, fever, easy bruising, and recurrent infections. Patients may also experience weight loss and night sweats, indicating disease progression.
How is acute leukemia of unspecified cell type diagnosed?
Diagnosis typically involves a complete blood count, bone marrow biopsy, and cytogenetic analysis to identify the presence of leukemic cells and assess disease status.
What treatment options are available for acute leukemia in relapse?
Treatment often includes chemotherapy, targeted therapy, and supportive care such as blood transfusions and infection management. The specific regimen depends on the patient's overall health and previous treatments.
How does ICD-10 Code C95.02 impact billing?
ICD-10 Code C95.02 is essential for accurate billing as it specifies the diagnosis of acute leukemia in relapse, ensuring that healthcare providers are reimbursed for the appropriate level of care and treatment provided.
Clinical Notes
SOAP notes
DAP notes
AI medical notes